In episode 17 we discuss buprenorphine-naloxone vs. buprenorphine alone in pregnancy.
Perry, Briana N. MD; Vais, Simone MD; Boateng, Jeffery O. MBchB, MPH; Jain, Mayuri MPH; Wachman, Elisha M. MD; Saia, Kelley A. MD. Buprenorphine-naloxone Versus Buprenorphine for Treatment of Opioid Use Disorder in Pregnancy. Journal of Addiction Medicine 16(6):p e399-e404, 11/12 2022.
We also discuss opioid-induced urinary retention, and the legalization of psilocybin in Oregon for treatment of alcohol use disorder and depression.
Guy M. Goodwin, et. al. Single-Dose Psilocybin for a Treatment-Resistant Episode of Major Depression.
N Engl J Med 2022; 387:1637-1648. November 3, 2022
----------
This podcast offers category 1 and MATE-ACT CME credits through MI CARES and Michigan State University. To get credit for this episode and others, go to this link to make your account, take a brief quiz, and claim your credit. To learn more about opportunities in addiction medicine, please visit MI CARES.
---------
Episode 17 Credits:
Original theme music: composed and performed by Benjamin Kennedy
Audio production: Erin McCue
Produced by: Dr. Patrick Beeman and Ars Longa Media
----------
This is Addiction Medicine Journal Club with Dr. Sonya Del Tredici and Dr. John Keenan. We practice addiction medicine and primary care, and we believe that addiction is a disease that can be treated. This podcast reviews current articles to help you stay up to date with research that you can use in your addiction medicine practice.
The best part of any journal club is the conversation. Send us your comments on Twitter, Facebook, YouTube, email, or join our Facebook group.
Email: addictionmedicinejournalclub@gmail.com
Twitter: @AddictionMedJC
Facebook: @AddictionMedJC
Facebook Group: Addiction Medicine Journal Club
YouTube: addictionmedicinejournalclub
Addiction Medicine Journal Club is intended for educational purposes only and should not be considered medical advice. The views expressed here are our own and do not necessarily reflect those of our employers or the authors of the articles we review. All patient information has been modified to protect their identities.
Learn more about your ad choices. Visit megaphone.fm/adchoices
